- 4 days & nights inpatient stay
- 11 quick follow-up appointments
This clinical trial has been approved by an independent ethics committee.
About the study
We need healthy males for a medication comparison study. This is a biosimilar study which means we are comparing an approved medication with another almost identical version.
Participants in this will be given either an approved medication (Omalizumab) or an almost identical version.
At this stage of testing we are not looking at whether it will have any therapeutic value, so we require healthy people who have never had asthma previously to participate.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Allergen Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!